Management of endocrine disease: Osteogenesis imperfecta: An update on clinical features and therapies

R Marom, BM Rabenhorst… - European journal of …, 2020 - academic.oup.com
Osteogenesis imperfecta (OI) is an inherited skeletal dysplasia characterized by bone
fragility and skeletal deformities. While the majority of cases are associated with pathogenic …

Osteogenesis imperfecta: advancements in genetics and treatment

V Rossi, B Lee, R Marom - Current opinion in pediatrics, 2019 - journals.lww.com
Osteogenesis imperfecta is a skeletal dysplasia characterized by bone fragility and
extraskeletal manifestations. Better understanding of the mechanisms of osteogenesis …

Optoacoustic imaging in endocrinology and metabolism

A Karlas, MA Pleitez, J Aguirre… - Nature Reviews …, 2021 - nature.com
Imaging is an essential tool in research, diagnostics and the management of endocrine
disorders. Ultrasonography, nuclear medicine techniques, MRI, CT and optical methods are …

Approach to the patient: pharmacological therapies for fracture risk reduction in adults with osteogenesis imperfecta

W Liu, B Lee, SCS Nagamani, L Nicol… - The Journal of …, 2023 - academic.oup.com
Context Osteogenesis imperfecta (OI) is a genetic disorder characterized by increased bone
fragility largely caused by defects in structure, synthesis, or post-translational processing of …

Bone control of muscle function

G Battafarano, M Rossi, F Marampon… - International journal of …, 2020 - mdpi.com
Bone and muscle represent a single functional system and are tightly connected to each
other. Indeed, diseases characterized by alterations of muscle physiology have effects on …

Emerging Landscape of Osteogenesis Imperfecta Pathogenesis and Therapeutic Approaches

Y Sun, L Li, J Wang, H Liu, H Wang - ACS Pharmacology & …, 2024 - ACS Publications
Osteogenesis imperfecta (OI) is an uncommon genetic disorder characterized by shortness
of stature, hearing loss, poor bone mass, recurrent fractures, and skeletal abnormalities …

Osteogenesis imperfecta in children

F Arshad, N Bishop - Bone, 2021 - Elsevier
Osteogenesis imperfecta (OI) is a disease characterised by altered bone tissue material
properties together with abnormal micro and macro-architecture and thus bone fragility …

[HTML][HTML] Skeletal pathology in mouse models of Gould syndrome is partially alleviated by genetically reducing TGFβ signaling

C Labelle-Dumais, C Mazur, S Kaya, Y Obata, B Lee… - Matrix Biology, 2024 - Elsevier
Skeletal defects are hallmark features of many extracellular matrix (ECM) and collagen-
related disorders. However, a biological function in bone has never been defined for the …

Extra-skeletal manifestations in Osteogenesis Imperfecta Mouse Models

TK Crawford, BN Lafaver, CL Phillips - Calcified Tissue International, 2024 - Springer
Osteogenesis imperfecta (OI) is a rare heritable connective tissue disorder of skeletal
fragility with an incidence of roughly 1: 15,000. Approximately 85% of the pathogenic …

Impaired muscle parameters in adults with mild to severe types of osteogenesis imperfecta: a cross-sectional study

M Coussens, B Lapauw, I De Wandele… - Journal of Bone and …, 2024 - academic.oup.com
Impaired muscle parameters may further compromise the already compromised skeleton in
individuals with OI. This cross-sectional study aimed to compare muscle function and body …